➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Medtronic
AstraZeneca
Mallinckrodt
Johnson and Johnson

Last Updated: April 15, 2021

DrugPatentWatch Database Preview

Drug Sales Trends for LEVEMIR

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Payment Methods and Pharmacy Types for LEVEMIR (2018)

Revenues by Pharmacy Type

Pharmacy Type Revenues
$2,074,915,034
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
3,842,973
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $254,549,495
MEDICARE $1,709,535,664
[disabled in preview] $1,724,592,782
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for LEVEMIR
Drug Units Sold Trends for LEVEMIR

Annual Sales Revenues and Units Sold for LEVEMIR

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
LEVEMIR   Start Trial   Start Trial 2018
LEVEMIR   Start Trial   Start Trial 2017
LEVEMIR   Start Trial   Start Trial 2016
LEVEMIR   Start Trial   Start Trial 2015
LEVEMIR   Start Trial   Start Trial 2014
LEVEMIR   Start Trial   Start Trial 2013
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Mallinckrodt
Boehringer Ingelheim
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.